These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2284831)

  • 1. [Papaverin--effective in therapy of pruritus of atopic dermatitis?].
    Hoting E; Reiss J; Schulz KH
    Z Hautkr; 1990 Aug; 65(8):725-9. PubMed ID: 2284831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
    Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
    Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
    Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis.
    Donsky H; Clarke D
    Am J Ther; 2007; 14(5):442-6. PubMed ID: 17890932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of papaverine to reduce pruritus in atopic dermatitis: a double-blind, placebo-controlled cross-over study.
    Berth-Jones J; Graham-Brown RA
    Br J Dermatol; 1990 Apr; 122(4):553-7. PubMed ID: 2186776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
    Andoh T; Yoshida T; Kuraishi Y
    Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
    Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of itching in atopic eczema.
    BMJ; 1989 Feb; 298(6671):461. PubMed ID: 2564794
    [No Abstract]   [Full Text] [Related]  

  • 14. Involvement of substance P in scratching behaviour in an atopic dermatitis model.
    Ohmura T; Hayashi T; Satoh Y; Konomi A; Jung B; Satoh H
    Eur J Pharmacol; 2004 May; 491(2-3):191-4. PubMed ID: 15140636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis.
    Fujii M; Nakamura T; Fukuno S; Mizutani N; Nabe T; Kohno S
    Eur J Pharmacol; 2009 Jun; 611(1-3):92-9. PubMed ID: 19344707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eczema molluscatum in tacrolimus treated atopic dermatitis.
    Wetzel S; Wollenberg A
    Eur J Dermatol; 2004; 14(1):73-4. PubMed ID: 14965804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice.
    Yatsuzuka R; Inoue T; Jiang S; Nakano Y; Kamei C
    Eur J Pharmacol; 2007 Jun; 565(1-3):225-31. PubMed ID: 17459367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of the activity of biologically active substances for the relief of itching in atopic dermatitis].
    Glukhen'kiĭ BT; Grando SA
    Sov Med; 1985; (9):115-7. PubMed ID: 2416064
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.